4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-035992
Chief Financial Officer bought 7,100 shares at $2.43 ($17,253)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patience David Chief Financial Officer | 2026-05-15 | Purchase | +7,100 | $2.43 | $17,253 | 275,757 | D |
| Open-market purchases · 7,100 sh · avg $2.43 · $17,253 | |||||||
Loading xslF345X06/wk-form4_1779136942.xml…